Form 4 for LLY Lilly (Eli)
Accepted 2024-11-01 00:00:00 ET · period of report 2024-10-31 · accession 0000059478-24-000247 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-01 | 2024-10-31 | LLY | Van Naarden Jacob | EVP, Pres, Lilly Oncology | G - Gift | $0.00 | -4,302 | 11.8K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-31 | G | D | 4,302 | $0.00 | 11,845 | D | — | — | (F1) The reporting person transferred 4,302 shares of Eli Lilly and Company common stock to the reporting person's spouse. |